[1]中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊断标准[J].中华肝脏病杂志, 2003, 11 (2) ∶71.
|
[2]李淑梅.胰岛素抵抗与高血压及抗高血压药物的关系[J].国外医学心血管分册, 2000, 27∶14-18.
|
[3]李光伟, 姜亚云, 杨文英, 等.胰岛素抵抗引起的代偿性高胰岛素血症预测非糖尿病人群血压升高[J].中国医学科学院学报, 2002, 24∶481-485.
|
[4]Park SH, KimBI, Yun Jw, et al.Insulin resistance and C-reactiveprotein as independent risk factors for non-alcoholic fatty liver dis-ease in non-obese Asian men[J].J Gastroenterol Hepatol, 2004, 19 (6) ∶694-698.
|
[5]范小芬, 邓银泉.非酒精性脂肪肝患者的胰岛素抵抗状态[J].浙江医学.2002, 24 (5) ∶267-269.
|
[6]魏良洲, 杨正武.瘦素、胰岛素在非酒精性脂肪肝发病中的作用[J].临床肝胆病杂志.2006, 22 (1) ∶72.
|
[7]Donati G, StagniB, Piscaglia F, et al.Increased prevalence of fattyliver in arterial hypertensive patients with nomal liver enzymes:role ofinsulin resistance[J].Gut, 2004, 53 (7) ∶923-924.
|
[8]Marchesini G, Brizi M, Bianchi G, et al.Non-alcoholic fatty liverdisease:a feature of the metabolic syndrome[J].Diabetes, 2001, 50∶1844-1850.
|
[1] | Wenqian YU, Linjun XIE, Shiyi LI, Yanmei LOU, Guoheng JIANG, Hongyu LI, Zitong YAN, Xuan BAI, Jing LUO, Chi ZHANG, Guangcan LI, Xuefeng SHAN, Xin WANG. Association between hypertension and the risk of gallstone disease[J]. Journal of Clinical Hepatology, 2024, 40(6): 1215-1225. doi: 10.12449/JCH240623 |
[2] | Sulian YANG, Rongjie SHI, Lihua LI. Value of Fetuin-A, Fetuin-B, and insulin resistance index in predicting nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2024, 40(4): 694-699. doi: 10.12449/JCH240409 |
[3] | Heng ZHU, Weizong KONG, Guiqun HUANG, Yu BAI, Yingchun WANG. Influence of histone deacetylase 1 on insulin resistance in a cell model of nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2022, 38(9): 2010-2015. doi: 10.3969/j.issn.1001-5256.2022.09.013 |
[4] | Yijing LIU, Zhenzhen ZHAO, Shousheng LIU, Yanyan XU, Yongning XIN. Correlation of serum alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transpeptidase, and alkaline phosphatase with blood pressure in patients with nonalcoholic fatty liver disease in coastal regions of Shandong Province in China[J]. Journal of Clinical Hepatology, 2021, 37(9): 2144-2147. doi: 10.3969/j.issn.1001-5256.2021.09.027 |
[5] | WANG Xin, HU YiYang, LIU Ping, FENG Qin. Association between hypertension and nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2020, 36(11): 2584-2588. doi: 10.3969/j.issn.1001-5256.2020.11.042 |
[6] | Dou AiHua, Hui Wei, Liu Mei, Wei LinLin, Zhao Juan, Ma ChunHua, Zheng XiaoQin, Xiong Fang, Yang Xue, Zhang Mei, Xu Bin. Association between rs2943650 mutation and insulin resistance in patients with chronic liver disease and type 2 diabetes mellitus[J]. Journal of Clinical Hepatology, 2018, 34(11): 2379-2382. doi: 10.3969/j.issn.1001-5256.2018.11.022 |
[7] | Liu DaJi, Chen QingFeng. Pathogenesis of insulin resistance and its impact on antiviral therapy in patients with chronic hepatitis C[J]. Journal of Clinical Hepatology, 2017, 33(6): 1152-1155. doi: 10.3969/j.issn.1001-5256.2017.06.029 |
[8] | Ding ZhiYong, Bu Le, Lu HongYan, Rao ZhengXuan. Correlation of liver fat content with serum vitamin A level and insulin resistance in patients with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2017, 33(12): 2361-2365. doi: 10.3969/j.issn.1001-5256.2017.12.021 |
[9] | Wang JinJun, Wang QinQin, Liu XinYan, Li YingMei, Xiong WuJun. Association between serum preptin level and insulin resistance in patients with nonalcoholic fatty liver disease[J]. Journal of Clinical Hepatology, 2016, 32(9): 1774-1777. doi: 10.3969/j.issn.1001-5256.2016.09.030 |
[10] | Zhang QiuNan, Xiao Ying, Miao RuiXin, Zhang YaQing, Zhu Ying. Changes in intestinal flora in nonalcoholic fatty liver disease: their correlation with insulin resistance index,tumor necrosis factor- α,and interleukin- 6[J]. Journal of Clinical Hepatology, 2015, 31(7): 1078-1081. doi: 10.3969/j.issn.1001-5256.2015.07.019 |
[11] | Yu LingXiang, Tan JunYuan, Xu ZhiWei, Jin XueYuan. Study on prevalence of hypertension in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(11): 1182-1185. doi: 10.3969/j.issn.1001-5256.2014.11.023 |
[12] | Li JingYu, Xu LiYang, Zhang Qiang, Liu Ming. Interventional diagnosis and therapy of portal hypertension resulting from hepatic vascular abnormalities[J]. Journal of Clinical Hepatology, 2011, 27(6): 643-646. |
[13] | Ma LiNa, Feng Ming, Zhou YingZhi, Ma Jia, Hao Peng. The relationship between nonalcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2010, 26(2): 173-174+177. |
[14] | Xu Hui, Wen QinSheng, Wang XuXia, Zhang YaFei, Li Jun, Gu BingQuan. The effect of cimetidine on the blood sugar, serum insulin and other indexes in NASH rats[J]. Journal of Clinical Hepatology, 2007, 23(2): 112-114. |
[15] | Yu XiaoHu, Zhu JinShui, Gu GuoMei, Shi JianPing. Clinical effect of oxymatrine combined with metformin on insulin resistance and serum TNF-α in patients with non-alcoholic fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(3): 195-196. |
[16] | Li YuQin, Po YunFeng, Chen ZhaoJie, Ding BaiJing, Tang TongYu, Wang Dan, Gao YanHang, Jin JingLan. Relationship between the levels of serum leptin and insulin resistance in patients with fatty liver[J]. Journal of Clinical Hepatology, 2007, 23(5): 360-361. |
[18] | Liang Bing, Chen Xi, Liu ShuangYan, Wang YiGe, An QiuHong. The relationship between non-alcoholic fatty liver disease and insulin resistance[J]. Journal of Clinical Hepatology, 2006, 22(3): 213-214. |
[19] | Huang JiLiang, Wu Fang, Zhang XinRan, Wang DongHua, Zhao RuiZhi. Relationship between tumor necrosis factor-α and lnsulin resistance in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2002, 18(3): 166-167. |
[20] | Ma YingJie, Fang LiFeng, Feng SuPing, Jia KeLi, Fu ZhenLie. Obesity and insulin resistance in nonalcoholic fatty liver[J]. Journal of Clinical Hepatology, 2002, 18(4): 241-242. |